Head-to-head
CoreAge Rx vs Invyncible
CoreAge Rx and Invyncible both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxInvyncible
Ranked #119 · Grade C
Best for: A mom who wants the option to start compounded and later move to a brand-name pen without switching providers.
Visit InvyncibleThe verdict
CoreAge Rx edges out Invyncible on the Rx-Readiness Score, 95 to 53 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Invyncible is still a genuine option — invyncible will sell a working mom either cheaper compounded semaglutide ($192.50/mo against a $275.00 reference price) or tirzepatide ($210/mo against $300.00), or an FDA-approved Wegovy ($1,750/mo) or Zepbound ($1,540/mo) pen, on the same account — genuinely useful if your needs change — but it won't confirm your state's availability until you're already in the intake, and it discloses its corporate parent and street address rather than hiding behind a trade name, a LegitScript seal displayed alongside it. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Invyncible |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 53/100 · C |
| Overall rank | #1 | #119 |
| Semaglutide | $99/mo | $192.50/mo |
| Tirzepatide | $149/mo | $210/mo |
| Coverage | All 50 states | Not publicly disclosed; confirmed during intake |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Invyncible
Ranked #119 · Grade C
What we like
- Names its corporate parent and a physical address rather than an anonymous storefront
- LegitScript-verified
- Both compounded programs and FDA-approved brand Wegovy/Zepbound on one account
The caveats
- No state-availability list — confirmed only during intake
- No published time-to-first-dose
- Every price is displayed as a permanent 'sale' against a higher reference figure that never appears to actually apply
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Invyncible against other providers on our shortlist.
Or browse the full comparison hub.